(Q44042280)

29 November 2017

title

Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure (English)

1 reference

29 November 2017

0 references

11

P P Nawroth

1 reference

29 November 2017

S Müller-Krebs

1

1 reference

29 November 2017

L P Kihm

2

1 reference

29 November 2017

B Zeier

3

1 reference

29 November 2017

M L Gross

4

1 reference

29 November 2017

R Deppisch

5

1 reference

29 November 2017

A Wieslander

6

1 reference

29 November 2017

T Henle

7

1 reference

29 November 2017

I Penndorf

8

1 reference

29 November 2017

J Oh

9

1 reference

29 November 2017

J Reiser

10

1 reference

29 November 2017

M Zeier

12

1 reference

29 November 2017

V Schwenger

13

1 reference

29 November 2017

publication date

16 March 2008

1 reference

European Journal of Clinical Investigation

29 November 2017

published in

1 reference

29 November 2017

volume

38

1 reference

29 November 2017

issue

5

1 reference

29 November 2017

page(s)

296-305

1 reference

The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Glucose degradation products in PD fluids: do they disappear from the peritoneal cavity and enter the systemic circulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Role of growth hormone in the development of experimental renal scarring

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Glomerular expression of nephrin and synaptopodin, but not podocin, is decreased in kidney sections from women with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

The role of the podocyte in glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

N-Terminal pyrazinones: a new class of peptide-bound advanced glycation end-products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

3,4-di-deoxyglucosone-3-ene promotes leukocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

3,4-Dideoxyglucosone-3-ene induces apoptosis in renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Advanced glycation end product-induced apoptosis and overexpression of vascular endothelial growth factor and monocyte chemoattractant protein-1 in human-cultured mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

Changing prescribing practice in CAPD patients in Korea: increased utilization of low GDP solutions improves patient outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01945.X

10.1111/J.1365-2362.2008.01945.X

21 January 2018

Identifiers

DOI

1 reference

release_zqwdpol5erbyforsi5g45yw23e

29 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/zqwdpol5erbyforsi5g45yw23e

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference